A major emphasis of the Wisconsin ADRC is identifying features and avenues for early intervention in the preclinical state of AD. Project 1 of the Wisconsin ADRC is about early characterization of AD using a fibrillar amyloid positron emission tomography imaging method with Pittsburgh Compound B [C11]PiB. We seek to determine the relationship between amyloid binding measured with PiB,and neural activity where neural activity is indexed by a) cognitive function/decline, b) BOLD activity during a memory task, and c) resting cerebral blood flow (CBF) imaging in a cohort of cognitive decliners at high risk for AD. The overall hypothesis is that fibrillar amyloid binding to [C11JPIB will be related to markers of neural function in cognitive decliners at high risk for AD. We will focus on the posterior cingulate/precuneus brain region (which is known to have high amyloid burden in AD) and probe this region with 1) a functional MRI task previously shown to activate the region, 2) resting cerebral blood flow (CBF) using a whole-brain pseudo- continuous arterial spin labeling technique (ASLCBF),and [C11]PIB imaging.
Specific Aim 1 : To determine whether PIB binding in the posterior cingulate is associated with cognitive decline to MCI in a cohort of subjects who we have followed over a 4-year interval. Furthermore we will determine whether PIB binding in the posterior cingulate predicts subsequent decline.
Specific Aim 2 : To determine whether PIB binding in the posterior cingulate is associated with imaging markers of neural function (BOLD fMRI during a memory task, and resting cerebral blood flow).
Specific Aim 3 : To determine if the relationship between PIB binding in the posterior cingulate is related to cerebral spinal fluid levels of amyloid-beta42 andtau. To accomplish these aims we will identify 30 subjects who have declined over the prior four years to MCI and match them to 30 cognitively-stable subjects over the same interval. All will participate in a single study visit to include PiB,fMRI, ASL CBF, and a lumbar puncture for CSF collection. All will be subsequently followed annually by the Clinical Core of the Wisconsin ADRC to determine their cognitive status including decline to AD. The data collected in this project will be analyzed to determine the relationship of PiB with prior and subsequent cognitive decline and imaging markers of neural function using voxel-wise statistics.

Public Health Relevance

(Seeinstructions): By the time a patient exhibits symptomatic dementia, devastating neural loss has already occurred. New methods for characterizing brain dysfunction are needed to facilitate early detection and early intervention. By applying advanced imaging to a well-characterized high-risk longitudinally-followed cohort, we are in a unique position to provide a greater understanding of early brain changes that occur in prodromal AD.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
United States
Zip Code
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Clark, Lindsay R; Koscik, Rebecca L; Allison, Samantha L et al. (2018) Hypertension and obesity moderate the relationship between ?-amyloid and cognitive decline in midlife. Alzheimers Dement :
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Martin, Stephen A; Souder, Dylan C; Miller, Karl N et al. (2018) GSK3? Regulates Brain Energy Metabolism. Cell Rep 23:1922-1931.e4
Swanson, Ashley; Wolf, Tovah; Sitzmann, Alli et al. (2018) Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins. Behav Brain Res 347:49-56
Gilmore-Bykovskyi, Andrea (2018) Commentary on Apathy as a Model for Investigating Behavioral and Psychological Symptoms in Dementia. J Am Geriatr Soc 66 Suppl 1:S13-S16
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Johnson, Sterling C; Koscik, Rebecca L; Jonaitis, Erin M et al. (2018) The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions. Alzheimers Dement (Amst) 10:130-142

Showing the most recent 10 out of 374 publications